Approved Symbol |
Approved Name |
Location |
Type |
No. of Association Studies (Positive/Negative/Trend)  |
Evidence[PMID] |
COBL |
cordon-bleu WH2 repeat protein |
7p12.2-p12.1 |
Literature-origin |
2(1/1/0)
|
ISS
|
GABRA2 |
gamma-aminobutyric acid (GABA) A receptor, alpha 2 |
4p12 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
3(1/2/0)
|
IEA
|
PTK2B |
protein tyrosine kinase 2 beta |
8p21.1 |
Mapped by LD-proxy |
0
|
IEA
|
COMT |
catechol-O-methyltransferase |
22q11.21 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
21(9/12/0)
|
IEA
|
HTR2A |
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
13q14-q21 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
4(2/2/0)
|
IEA
|
GARS |
glycyl-tRNA synthetase |
7p15 |
Mapped by LD-proxy, rSNP target |
0
|
IDA[17035524]
|
MAPT |
microtubule associated protein tau |
17q21 |
Mapped by LD-proxy, rSNP target |
0
|
IDA[8642405]
|
SLC6A3 |
solute carrier family 6 (neurotransmitter transporter), member 3 |
5p15.3 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
21(11/10/0)
|
IDA[12958153]
|
BLOC1S2 |
biogenesis of lysosomal organelles complex 1 subunit 2 |
10q24.31 |
rSNP target |
0
|
IEA; ISS
|
DTNBP1 |
dystrobrevin binding protein 1 |
6p22.3 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
5(2/3/0)
|
ISS
|
ADRB2 |
adrenoceptor beta 2 |
5q31-q32 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/1/0)
|
IEA
|
CNR1 |
cannabinoid receptor 1 (brain) |
6q14-q15 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
2(0/2/0)
|
IEA
|
DRD2 |
dopamine receptor D2 |
11q23.2 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
18(11/7/0)
|
ISS
|
CCK |
cholecystokinin |
3p22.1 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
1(1/0/0)
|
ISS[15152034]
|
RAB21 |
RAB21, member RAS oncogene family |
12q21.1 |
rSNP target |
0
|
IEA
|
RAB5A |
RAB5A, member RAS oncogene family |
3p24.3 |
rSNP target |
0
|
ISS
|